Loading clinical trials...
Loading clinical trials...
OBJECTIVE To evaluate the efficacy of bromfenac ophthalmic solution 0.09% for reducing postoperative inflammation in eyes with pseudoexfoliation syndrome (PEX) undergoing cataract surgery and receivin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Azienda USL Reggio Emilia - IRCCS
NCT06616506 · Cataract, High Myopia, and more
NCT07462000 · Primary Open-Angle Glaucoma (POAG), Cataract
NCT07452770 · Pain, Fear, and more
NCT06979752 · Glaucoma, Open Angle, Pseudo-exfoliative, Cataract
NCT07362043 · Cataract Surgery
Arcispedale Santa Maria Nuova IRCSS - Ophthalmology
Reggio Emilia, RE
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions